Clinical Report
Posterior sub-tenon’s injection of triamcinolone acetonide in the treatment of optic disc vasculitis
Liu Yi, Liu Decheng
Published 2020-02-25
Cite as Chin J Ocul Traum Occupat Eye Dis, 2020, 42(2): 117-121. DOI: 10.3760/cma.j.issn.2095-1477.2020.02.008
Abstract
ObjectiveTo evaluate the efficacy of posterior sub-tenon’s injection of triamcinolone acetonide in the treatment of optic disc vasculitis.
MethodsThe clinical data of 60 eyes of 60 patients with optic disc vasculitis from May 2016 to May 2019 in the Seventh People’s Hospital of Zhengzhou were retrospectively analyzed. Triamcinolone acetonide 40 mg/0.5 ml was injected into Tenon’s capsule with a self-made gauge 6 lacrimal irrigation needle, and compound Xueshuantong and energy mixture were infused intravenously, compound anisodine injection was injected subcutaneously beside superficial temporal artery, methylcobalamin, citicoline and compound vitamin B were taken orally. All patients were followed up for 6-18 months.
ResultsAll 60 cases were cured within 6 to 18 months after treatment. The visual acuity were improved and the shape of macular fovea were restored, macular edema were alleviated.
ConclusionPosterior sub-tenon’s injection of triamcinolone acetonide in the treatment of optic disc vasculitis is safe, effective, simple and inexpensive.
Key words:
Vasculitis, optic disc; Triamcinolone acetonide, injection, sub-tenon’s posterior; Efficacy, clinical
Contributor Information
Liu Yi
Department of Ophthalmology, The Seventh People’s Hospital of Zhengzhou, Zhengzhou 450016, China
Liu Decheng
Department of Ophthalmology, The Seventh People’s Hospital of Zhengzhou, Zhengzhou 450016, China